Recently, Porton Pharma Solutions Ltd. (“Porton”) announced a strategic partnership with Aojin Life Sciences (Yixing) Co., Ltd. (“Aojin Life Sciences”).
Porton will provide comprehensive CDMO services for Aojin in the CMC pharmaceutical research and GMP production of XDC conjugate drugs, …
Porton was recently selected as a “2024 Exemplary Case for Sustainable Development Among Chinese Listed Companies” by the China Association of Public Companies, in recognition of its Environmental, Social, and Governance (ESG) management practices once again.
Porton has disclosed its …
With a Focus on Globalization, Innovative Technology Platforms, and Accelerating Your New Business Opportunities into the Clinic and to the Market.
The newly revamped website strategically highlights our commitment to a global service model, offering an enhanced customer experience through …
During the Slovenian government delegation’s visit to Shanghai, the Slovenian Consulate in Shanghai and the Shanghai Municipal Commission for Trade Promotion hosted the “China–Slovenia Business and Investment Forum” on November 4th, 2024. This event brought together senior Slovenian government officials, …
On November 7, 2024, the New Modality Capacity Upgrade Ceremony was successfully held in Fengxian, Shanghai, China. Attendees included Mr. Weng Jun，Vice General Manager，Shanghai Hangzhou Bay Economic & Technological Development Co., Ltd., Mr. Bai Yinchun, COO and Senior Vice President …
Recently, Porton Pharma has achieved a significant capacity breakthrough at its GMP manufacturing facility in Fengxian, Shanghai, China, further enhancing its production capabilities and technological strength in new modality areas such as peptide and oligonucleotide drugs. This upgrade represents an …
On October 24, 2024, Porton Pharma SolutionsLtd. (“Porton”) announced a strategic partnership with Shanghai InnoStar Bio-tech Co., Ltd. (“InnoStar”) in Shanghai. The distinguished signing ceremony was attended by Mr. Ju Nianfeng, Chairman and CEO of Porton; Dr. Chang Yan, President …
Recently, the three-day 2024 CPHI Milan exhibition concluded successfully in Milan, Italy. As a leading global platform for showcasing the most advanced development of pharmaceutical industry , the event attracted numerous international pharmaceutical and biopharmaceutical companies. Porton Pharma Solutions, one …
The AAPS PharmSci 360, held from October 20-23, 2024, is an eminent event in the pharmaceutical industry, renowned for its convergence of key players, thought leaders, and innovative companies from across the globe. This year, Porton J-STAR invites you to …
Recently, Dr. Yuriy Abramov and Dr. Jian Wang from Porton’s team of global chemical engineering and technology published a Communication paper titled “Is It Salt, Cocrystal, or Continuum? Successes and Limitations of Computationally Efficient Periodic System Calculations” in Crystal Growth …
CPhI Europe stands as a worldwide event in the pharmaceutical industry, bringing together key players, thought leaders, and businesses from across the globe. The event serves as an unparalleled platform for powerful networking, fostering collaborations, and driving forward the growth …
In an effort to foster stronger interactions with industry professionals, we have organized two dedicated presentation sessions at booth 5C17 on October 9. Our expert speakers will deliver advanced technical insights and industry perspectives, offering attendees a deep dive into …
